Ophthalmic Manifestations in Chronic Inflammatory Rheumatic Diseases at a Referral Hospital of Yaounde, Cameroon

REFERENCES

• Ntsiba H, Ngandeu-Singwe M, Mbuyi Muamba J. Les connectivites en Afrique Centrale. 2009. Available at http://poster.rhumatologie.asso.fr. Accessed January 5, 2015.
   Google Scholar
• Singwe-Ngandeu M, Meli J, Ntsiba H, et al. Rheumatic diseases in patients attending a clinic at a referral hospital in Yaounde, Cameroon. East Afr Med J. 2007; 84(9):404–409.
   PubMedGoogle Scholar
• Terrada C, Prieur AM, Bodaghi B. Les atteintes oculaires au cours des maladies rhumatismales de l’enfant. Médecine thérapeutique/Pédiatrie. 2006; 9(1):57–62.
   Google Scholar
• Marvillet I, Terrada C, Quartier P, et al. La menace oculaire au cours des arthrites juvéniles idiopathiques. Revue du Rhumatisme. 2009;76(7):673–679.
   Google Scholar
• Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum. 2001;30(4):217–241.
   PubMed Web of Science ®Google Scholar
• Reddy SC, Rao UR. Ocular complications of adult rheumatoid arthritis. Rheumatol Int. 1996;16(2):49–52.
   PubMed Web of Science ®Google Scholar
• Smith JR, Rosenbaum JT. Management of uveitis: a rheumatologic perspective. Arthritis Rheum. 2002;46(20):309–318.
   PubMedGoogle Scholar
• Kouakou ES, Diomande M, Yao JC, et al. Manifestations oculaires au cours de la polyarthrite rhumatoïde: à propos de 24 cas vus à Abidjan. Mali medical. 2014;29(3):33–35.
   Google Scholar
• Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010; 62(9):2569–2581.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–2686.
   PubMed Web of Science ®Google Scholar
• Amor B, Dougados M, Listrat V, et al. Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev Rhum Engl Ed. 1995;62(1):10–15.
   PubMedGoogle Scholar
• Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392.
   PubMed Web of Science ®Google Scholar
• Avouac J, Fransen J, Walker UA, et al. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70(3):476–481.
   PubMed Web of Science ®Google Scholar
• Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease–an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148–159.
   PubMed Web of Science ®Google Scholar
• Mijiyawa M, Etey K, Amedegnato MD. Rhumatismes inflammatoires chroniques en consultation hospitalière à Lomé (Togo). Rhumatologie. 1993;45(2):45–49.
   Google Scholar
• Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I. Arthritis Rheum. 2008;58(1):15–25.
   PubMed Web of Science ®Google Scholar
• Bileckot R, Malonga AC. La polyarthrite rhumatoïde en milieu hospitalier au Congo- Brazaville: A propos de 36 cas. Revue du rhumatisme. 1998; 65(5):333–337.
   Google Scholar
• Haddouk S, Ben Ayed M, Baklouti S, et al. Autoanticorps dans le lupus érythémateux systémique: Profil et corrélations cliniques. Pathologie Biologie. 2005; 53,311–317.
   Google Scholar
• Ghedira I, Sakly W, Jeddi M. Caractéristiques cliniques et sérologiques du lupus érythémateux systémique: A propos de 128 cas. Pathologie Biologie. 2002;50,18–24.
   PubMedGoogle Scholar
• Meyer, O. Lupus systémique chez les non-Caucasiens. Revue du Rhumatisme. 2002;69, 801–808.
   Google Scholar
• Daboiko JC, Gueret M, Eti E, et al. Profil clinique et évolutif du lupus érythémateux systémique: A propos de 49 cas colligés au CHU de Cocody. Médecine d’Afrique noire. 2004;51,143–146.
   Google Scholar
• Diallo S, Ndongo S, Pouye A, et al. Spondylarthrite ankylosante: étude de 141 cas au Sénégal. 2008. Available at http://poster.rhumatologie.asso.fr. Accessed January 5, 2015.
   Google Scholar
• Smolen JS, Van der Heijde D, Machold KP, et al. Proposal for a new nomenclature of disease-modifying antirheumatic drugs. Ann Rheum Dis. 2014.73(1):3–5.
   PubMed Web of Science ®Google Scholar
• Markovitz E, Perry ZH, Tsumi E, et al. [Ocular involvement and its’ manifestations in rheumatoid arthritis patients]. Harefuah. 2011;150(9):713–8, 751.
   PubMedGoogle Scholar
• Zlatanović G, Veselinović D, Cekić S, et al. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci. 2010;10(4):323–327.
   PubMed Web of Science ®Google Scholar
• Daboiko J, Abitche M, Eti E, et al. Les lésions oculaires au cours de la polyarthrite rhumatoïde: à propos de 24 cas. 2008. Available at http://poster.rhumatologie.asso.fr. Accessed January 5, 2015.
   Google Scholar
• Sitaula R, Shah DN, Singh D. The spectrum of ocular involvement in systemic lupus erythematosus in a tertiary eye care Center in Nepal. Ocul Immunol Inflamm. 2011;19(6):422–425.
   PubMed Web of Science ®Google Scholar
• Smith JR, Rosenbaum JT. Management of uveitis. A rheumatologic perspective. Arthritis Rheum. 2002;46(20):309–318.
   PubMedGoogle Scholar
• Palejwala NV1, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis. 2012;2012:290898.
   PubMedGoogle Scholar
• Gomes Bde A, Santhiago MR, Magalhães P, et al. Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 2011;66(3):379–385.
   PubMed Web of Science ®Google Scholar
• Ellong A, Ebana Mvogo C, Bella-Hiag AL, et al. La prévalence des glaucomes dans une population de noirs camerounais. Cahiers Santé. 2006;(16)2:83–88.
   PubMedGoogle Scholar
• Preussner PR, Grossmann A, Ngounou F, et al. Glaucoma screening in Western Cameroon. Graefes Arch Clin Exp Ophthalmol. 2009;247:1671–1675.
   Google Scholar
• Tripathi RC, Parapuram SK, Tripathi BJ, et al. Corticoids and glaucoma risk. Drugs Aging. 1999;15(6):439–450.
   PubMed Web of Science ®Google Scholar
• Bremer F. Origine de la cortico-sensibilité. Bull. Soc. belge Ophtalmol. 2007;304:111–116.
   PubMedGoogle Scholar
• Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111(4):802–809.
   PubMed Web of Science ®Google Scholar
• Sampaio-Barros PD, Conde RA, Bonfiglioli R, et al. Characterization and outcome of uveitis in 350 patients with spondyloarthropathies. Rheumatol Int. 2006;26(12):1143–1146.
   PubMed Web of Science ®Google Scholar
• Bella-Hiag A, Mvogo CE, Ellong A. Les uvéites: aspects épidémiologiques à l’hôpital Laquintinie de Douala. Ophthalmologica. 2001;215:30–33.
   PubMed Web of Science ®Google Scholar
• Herman K, Leys A, Spileers W. Hydroxy-chloroquine retinal toxicity: two case reports and safety guidelines. Bull Soc Belge Ophtalmol. 2002;284:21–29.
   PubMedGoogle Scholar
• Mavrikakis I, Sfikakis PP, Mavrikakis E, et al. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology. 2003;110(7):1321–1326.
   PubMed Web of Science ®Google Scholar